chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 4 year old black female with penicillin allergy who on 15-FEB-2008 was vaccinated intramuscularly into the left thigh with a second dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process) (lot #
This spontaneous report was received from a medical assistant regarding an unknown age patient of unknown gender. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. On 21-SEP-2017, the patient was vaccinated with PNEUMOVAX 23 for prophylaxis (dose, strength, frequency, lot#, expiration date and route of administration were not reported) and on 10-APR-2018, the patient was vaccinated with (crm197)PREVNAR 13 (manufacturer unknown) (dose, strength, frequency, lot#, expiration date, route of administration and indication were not reported). No adverse effects were reported. No product quality complain was present.
Headache; Weakness; Nausea; Feeling unwell; Dizziness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 59 year-old male patient received bnt162b2 (BNT162B2), administration date 10Mar2021 (Batch/Lot number: unknown) at the age of 59 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 10Mar2021, outcome "not recovered", described as "Headache"; ASTHENIA (non-serious) with onset 10Mar2021, outcome "not recovered", described as "Weakness"; NAUSEA (non-serious) with onset 10Mar2021, outcome "not recovered", described as "Nausea"; MALAISE (non-serious) with onset 10Mar2021, outcome "not recovered", described as "Feeling unwell"; DIZZINESS (non-serious) with onset 10Mar2021, outcome "not recovered", described as "Dizziness". The action taken for bnt162b2 was unknown. It was unknown if therapeutic measures were taken as a result of headache, asthenia, nausea, malaise, dizziness. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After 30 mins. pt c/o "scratcy" ThroaT. Pt moved To Treatment area.  Pt. voice started To sound "gravely" ang given 25mg benadryl. Approximately 10 mins. after benadryl pT. stated she was feeling better. Pt. monitored another 20mins. Pt. released and advised to call 911 w/ any further issues.   Adverse reactions or other concerns: Scratchy throat  Actions taken and other comments: After 30 mins. Pt stated her throat felt "scratchy'. PT. mmoved to Treatment area where hisTory and vitals obTained. PT. given 25mg benadryl. After approximately 10 mins. after benadryls administration PT. stated she felt better. PT. monitored another 20mins. PT. released and advised to call 911 w/any further issure.
Low grade fever and malaise X3 days. Within 12 hours developed hives at right wrist. This spread to left lower extremity. Treated with Benadryl and Claritin. Then prednisone 1 week later. Lesions resolved mostly
This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX lot # M039453 for prophylaxis. Concomitant therapies included sterile diluent. On an unknown date the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to ZOSTAVAX.
Pain on her left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on her left arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high (High Blood Pressure) and High cholesterol.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain on her left arm). At the time of the report, PAIN IN EXTREMITY (Pain on her left arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications reported were blood pressure pill and cholesterol pill.  No treatment information was provided.   This case was linked to MOD-2021-245629 (Patient Link).
I noticed at almost 24 hours past my injection (this was my 3rd dose or booster dose of the vaccine) a wave of hot flashes.  The next thing I noticed were the beginnings of hives on my forearms and torso.  Over night and into the 48 hours post vaccine, the hives worsened, spread to my neck, face, legs - almost looked like a sunburn.  I hardly slept due to aches and chills and overall irritation of the sensation of the hives.  At 72 hours, the hives are starting to lessen in intensity, though still very visually present - from 48-72 hours, there appeared to be additional spreading in my face.  I lost a day of work due to my physical state. I also am experiencing some brain fogginess and edema in my hands.   I have a very low sugar and low sodium diet and have not had any alcohol leading up to the vaccine or post vaccine as of this writing.  I do not smoke and do not have any health issues that I am aware of. I exercise regularly and practice mindfulness. And, I would say that about 90% of the food I eat is organic.   I have not been sick with a cold or flu or virus or bacteria in 4+years.
Within a minute or two of receiving the vaccine, I felt sweaty and dizzy.  Got up from the chair and walked out of the office and immediately felt faint.  Made it to the front of the store and plunked down between two potted plants near the entrance.  Sat there with my head down for a few minutes and got up and walked outside to the parking lot still feeling weak and dizzy.  Gave my car keys to a friend who had accompanied me so he could get us home.  After 20 mins in the car, felt fine and that continued.  Only a sore arm hours later.  Wondering  if I should receive second vaccine.
some GI side effects; metallic taste; diarrhea; upset stomach; some lymph node swelling in her left armpit; This spontaneous case was reported by a pharmacist and describes the occurrence of GASTROINTESTINAL DISORDER (some GI side effects), DYSGEUSIA (metallic taste), DIARRHOEA (diarrhea), ABDOMINAL DISCOMFORT (upset stomach) and VACCINATION SITE LYMPHADENOPATHY (some lymph node swelling in her left armpit) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GASTROINTESTINAL DISORDER (some GI side effects), DYSGEUSIA (metallic taste), DIARRHOEA (diarrhea), ABDOMINAL DISCOMFORT (upset stomach) and VACCINATION SITE LYMPHADENOPATHY (some lymph node swelling in her left armpit). At the time of the report, GASTROINTESTINAL DISORDER (some GI side effects), DYSGEUSIA (metallic taste), DIARRHOEA (diarrhea), ABDOMINAL DISCOMFORT (upset stomach) and VACCINATION SITE LYMPHADENOPATHY (some lymph node swelling in her left armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-396518 (Patient Link).
Intermittent pain in area of injection radiating across deltoid.  At times a burning sensation with tingling down inner and outer forearm.  Occasional pain in upper left shoulder in area of injection.
Narrative:  Vaccinated, not boosted pt admitted for bacterial PNA. Tested positive for COIVD during admission
Dizzy, fever 102-103 c/o face/head/shoulders hurting, headache.
fever to 102, irritable, unable to walk, bear weight or crawl;swollen warm around lt anterior lateral thigh;
Patient in the observation area reported that she felt dizzy and after that she vomited. The paramedics put her on a stretcher to stabilize her in the ambulance, they took her vitals. Initial pressure 80/60 (patient anemic, hypoglycemic, allergic to iodine) final pressure 100/80, 62 dextrose 94 sugar, 95 SAT, 85 pulse.
Vaccine not in list - SHINGRIX vial. Nausea vomiting headache diarrhea achiness.
28 year old female patient refers to paramedic " I can't breath" The patient is transferred to observation and treatment area. She is hyperventilation, cold to the touch and anxious. Vital signs continue to be measured at 5:43 pm, Dxt 138, BP 90/60, sat 98% and P-88 /m. Doctor is consulted, and recommends leaving the patient under observation for 30 minutes. 6:17 pm we proceed to re-evaluate vitals signs BP 100/70, sat 95%, pulse 88, resp 20p/m no presence of edema in the mouth. "patient refers feeling better".
Fever; Sore throat; Cough; Body aches; Weakness; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (Fever), OROPHARYNGEAL PAIN (Sore throat), COUGH (Cough), PAIN (Body aches) and ASTHENIA (Weakness) in a 94-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced PYREXIA (Fever), OROPHARYNGEAL PAIN (Sore throat), COUGH (Cough), PAIN (Body aches) and ASTHENIA (Weakness). At the time of the report, PYREXIA (Fever), OROPHARYNGEAL PAIN (Sore throat), COUGH (Cough), PAIN (Body aches) and ASTHENIA (Weakness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No treatment information was provided.   Company Comment: This case concerns a 94-year-old male who had NS events of unexpected oropharyngeal pain, cough, pain, asthenia and expected pyrexia. Event onset Day 10 after first dose mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.; Reporter's Comments: .; Sender's Comments: This case concerns a 94-year-old male who had NS events of unexpected oropharyngeal pain, cough, pain, asthenia and expected pyrexia. Event onset Day 10 after first dose mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.
Sweating, ears hurt, weakness, left arm swollen, red and rash around injection site, severe joint pain over entire body, headaches, chills, sore throat, eye pain, low-grade temp. at times - just plain miserable and uncomfortable - coughing, stuffy nose - when does this go away? Am I going to die from this?
Difficulty breathing, hoarseness, pale, weakness, fast heart beat and dizziness, Nausea and vomiting. Symptoms occured 11-12 hous after vaccine was given. Still  tiredness and weak 08/09/06
Fever 101F x 5 days, lt leg swollen, hot, red and very painful. Started after 3rd day of vaccination given from 4/6/06 to 4/11/06. Very fussy. TX Motrin susp 2ml TID.
Swelling and joint pain in lower legs from knees down and full left side. Progression to joint pain in arms chest... ribcage headache and extreme exhaustion. Low grade fever.
achiness in the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (achiness in the injection arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced INJECTION SITE PAIN (achiness in the injection arm). At the time of the report, INJECTION SITE PAIN (achiness in the injection arm) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No Concomitant medications were provided  No treatment medications were provided   This case was linked to, INC.-MOD-2021-077686 (E2B Linked Report).; Sender's Comments:  , INC.-MOD-2021-077686:2nd dose
Vaccine given 7/3/07 - 7/8 - 7/9 Neuralgia, L. arm and side and under right breast 7/10 PM, smothery feeling, rapid and irregular pulse, general malaise, sharp stabbing pain in left side and under left breast. 7/15 Rash appeared on inside of upper left arm. Neuralgia and pain under breast subsided. Rash area swollen.
Cold feet (with socks on) followed by chills and then fever (highest 101.2), now 100.4 at 11 PM after nap and two 325 mg aspirin.
Patient Sick- Can?t get up, Fever, chills, Had Covid Shot yesterday.  T 101.0-.5-6 P 72 R 32 BP 150/80 Sat 92 %   ?no strength.?  Hospitalized on 4/9/2021 with Sickle Cell Crisis
Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PREDNISONE, ETANERCEPT (ENBREL), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), METHOTREXATE and VITAMINS NOS for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (Soreness at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
- Stiffness in all joints - Tightness in chest - Nausea and vomiting - Feeling faint - Fatigue
This spontaneous report as received from a healthcare worker (her position at the office was "Vaccine Supervisor") refers to an unspecified number of patients of unknown age. On an unknown date the patients was vaccinated with improperly stored VARIVAX (Merck) (lot # unspecified). No symptoms reported. Additional information has been requested.
chills; 102 degree fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and PYREXIA (102 degree fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Medical history was not provided.    On 14-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced CHILLS (chills) and PYREXIA (102 degree fever). At the time of the report, CHILLS (chills) and PYREXIA (102 degree fever) outcome was unknown.            No concomitant medication were reported. No treatment information was reported.
Patient came in on 9-4-11 to show me a raised, red area around the site of her ZOSTAVAX injection. She said she feels no pain or discomfort only itching. I told her to keep an eye on it and if gets worse or no better by 9-6-11 to contact her doctor.
Rash, secondary transmission - Information has been received from a registered nurse concerning a female patient with a history of varicella who was exposed to her son who on 04 Apr 200 was vaccinated with varicella virus vaccine live.  Three days post vaccination, the patient devloped a rash all over that consisted of red spots.  The patient sought unspecified medical attention.  Additonal information has been requeste.
Hives all over. No shortness of breath. Just checked this afternoon and put on Atarax and Orapred.
Within 5 minutes of injection my tongue felt odd and I started to salivate. Shortly after, I found it difficult to swallow (as if throat) was closing up, numbness in lips, flush face, tingling in fingers. Liquid Benadryl (1 capful) was administered by mouth and within 10 minutes swallowing difficulty was less but still difficult. Within 30 minutes all symptoms subsided.  At no time did I have difficulty breathing, chest tightness, wheezing or any other anaphylaxis symptoms other than the ones described.
Patient received Pfizer BV vaccine on 9/13/2022 and then received it again on 9/30/2022.  Currently he has no symptoms and is being monitored by his school nurse.
01/24/2011 Moderate Other. Cellulitis noted today in right arm in area surrounding elbow. States he had swelling and redness with pain at injection site for 4 days. This is now gone. 6" x 4" mild redness. Warmth & swelling noted last night in elbow area. KEFLEX 500 mg TID x 10 days. Recheck appt 2-3-11.
This spontaneous report from a health professional refers to a patient of unknown age and gender. The patient's pertinent medical history and concurrent conditions were not reported. On an unknown date in July 2015, the patient was vaccinated with improperly stored, expired RECOMBIVAX HB (lot # H011741, expiry date 01-FEB-2015) dose, route unknown. Concomitant medications were not reported. No adverse effects were reported. Product quality complaint was not filed. This is one of the two cases received from the same reporter. Additional information has been requested.
SORE THROAT; CHEST CONGESTION; COUGH; HOARSENESS (LARYNGITIS); WEAKNESS
drug exposure during pregnancy; This prospective pregnancy case was reported by a pharmacist via call center representative and described the occurrence of vaccine exposure during pregnancy in a 26-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2019-2020 season) (batch number 3N4F7, expiry date 30th June 2020) for prophylaxis.   On 24th September 2019, the patient received Fluarix Quadrivalent 2019-2020 season. The patient's last menstrual period was on an unknown date and estimated date of delivery was 20th November 2019. The patient received Fluarix Quadrivalent 2019-2020 season during the third trimester of pregnancy. On 24th September 2019, unknown after receiving Fluarix Quadrivalent 2019-2020 season, the patient experienced vaccine exposure during pregnancy. On an unknown date, the outcome of the vaccine exposure during pregnancy was unknown. The pregnancy was ongoing.  Additional details were provided as follows: The reporter stated that, the patient with estimated date of delivery on or around 20th November 2019 received the vaccine, which led to vaccine exposure during pregnancy. No other events reported.
This spontaneous report was received from a nurse practitioner via company representative and refers to a 11 year old female patient. No information regarding the patient's pertinent medical history and drug reactions or allergies was reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL 9, intramuscularly for prophylaxis. Concomitant therapy included unspecified medication for pneumococcal. On an unknown date, the patient fainted after receiving dose of GARDASIL 9. It was not known which dose the patient was receiving. On an unspecified date, the patient recovered from syncope. The relationship between the event and GARDASIL 9 was not reported. Additional information is not expected as there was no consent to contact reporter.
Information has been received from a pharmacist concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provide. On 07-MAR-2016 the patient was vaccinated with a dose of ZOSTAVAX (1 dose form (DF), lot #, expiration date and route unspecified), which was reconstituted with expired sterile diluent (Merck Sterile Diluent) (lot # L003601, expiration date 24-JAN-2016). No adverse effects were reported. This is one of two received from the same source. Additional information has been requested.
I95.9 HYPOTENSION 11/30/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA
3 days ago, she had Pulmonary embolism; violently sick; losing her hair; Pain in the Injection site; feels that her arm is numb down to fingers and she can't hardly lift her arm; feels that her arm is numb down to fingers and she can't hardly lift her arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A female patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), on 05Sep2023 as dose 1, single (Batch/Lot number: unknown) for immunisation; for immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Pfizer covid vaccine (Dose 1), for COVID-19 immunization; Pfizer covid vaccine (Dose 2), for COVID-19 immunization; Pfizer covid vaccine (Dose 3), for COVID-19 immunization, reaction(s): "falling hair", "violently sick", "pulmonary embolism". The following information was reported: PULMONARY EMBOLISM (medically significant) with onset Sep2023, outcome "unknown", described as "3 days ago, she had Pulmonary embolism"; VACCINATION SITE PAIN (non-serious) with onset Sep2023, outcome "not recovered", described as "Pain in the Injection site"; JOINT RANGE OF MOTION DECREASED (non-serious), HYPOAESTHESIA (non-serious) all with onset Sep2023, outcome "unknown" and all described as "feels that her arm is numb down to fingers and she can't hardly lift her arm"; ALOPECIA (non-serious) with onset Sep2023, outcome "unknown", described as "losing her hair"; MALAISE (non-serious) with onset Sep2023, outcome "unknown", described as "violently sick".  Clinical course details: The case was reported as non-serious. The caller mentioned that she got the RSV vaccine Abrysvo last 05Sep and has a reaction. The patient was currently experiencing pain in the injection site. She also added that she also feels that her arm was numb down to the fingers and she can't hardly lift her arm. She said her arm had no mark or redness, but it hurts on the injection site and it's going on for three weeks since she had it. She was asking if there was anything she can do to get rid of the pain. In addition, her pharmacy advised her to inform us about that she got violently ill when she had her third Pfizer COVID vaccine. According to the patient, she had a terrible reaction to the Covid vaccine where she received 3 shots. She added that 3 days ago, she had pulmonary embolism, she was losing her hair, and she was violently sick. She would also like to know what she could do about this.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
THE PATIENT NOTED A LUMP IN HER THROAT, AND SUBSEQUENTLY THE ONSET OF CHILLS. LATER IN THE EVENING, SHE FELT HOT. HER SYMPTOMS HAD ABATED BY THE FOLLOWING DAY.